Quantcast

Latest Pemetrexed Stories

2014-02-19 08:31:13

-- Ramucirumab Improved Survival in Second-Line Study of Patients with Non-Small Cell Lung Cancer -- INDIANAPOLIS, Feb. 19, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the REVEL trial, a global Phase III study of ramucirumab in combination with chemotherapy in patients with second-line non-small cell lung cancer (NSCLC), showed a statistically significant improvement in the primary endpoint of overall survival in the ramucirumab-plus-docetaxel arm...

2014-01-16 23:24:20

Researchers recommend that drug choice be guided by aspects of the patient’s condition. Raleigh, NC (PRWEB) January 16, 2014 Surviving Mesothelioma is reporting on newly published research suggesting that certain aspects of a peritoneal mesothelioma patient’s condition may have an impact on the toxicity of chemotherapy. A combination of pemetrexed (Alimta) and a platinum-based drug like cisplatin or carboplatin is the drug treatment of choice for patients with pleural mesothelioma,...

2014-01-04 23:01:12

Scientists in Japan and Austria say the kinase inhibitor temsirolimus stops mesothelioma growth in two different ways. Raleigh, NC (PRWEB) January 04, 2014 A new study published in the journal Oncology Reports and detailed by Surviving Mesothelioma suggests that temsirolimus, a kinase inhibitor used to treat advanced renal cell carcinoma (RCC), may offer a promising new way to treat malignant pleural mesothelioma. The group studied temsirolimus by itself and in combination with the...

2014-01-02 23:25:36

Australian researchers say bromelain may be the key to making chemotherapy more effective for mesothelioma patients. Raleigh, NC (PRWEB) January 02, 2014 A study conducted in Australia and reported by Surviving Mesothelioma finds that a compound derived from the stems of pineapples appears to be able to improve standard drug treatment for peritoneal mesothelioma. Bromelain has a history of use in folk medicine and is believed to have anti-inflammatory effects.Previous studies have found...

2013-12-14 23:01:48

Scientists in Italy say vinorelbine may be a promising option for patients whose cancer returns after chemotherapy. Raleigh, NC (PRWEB) December 14, 2013 The anti-mitotic drug vinorelbine may be a safe and effective treatment for mesothelioma patients whose cancer progresses after first-line chemotherapy with the standard drugs. Pemetrexed (Alimta) is the primary first-line chemotherapy drug for mesothelioma patients with unresectable disease. The drug is usually paired with a...

2013-12-10 23:27:00

Turkish researchers say a new drug may make a standard chemotherapy drug more effective – and less toxic – for patients fighting malignant mesothelioma. Raleigh, NC (PRWEB) December 10, 2013 Surviving Mesothelioma is reporting on a promising new drug study published in Genetic and Molecular Research. The study suggests that panobinostat, an experimental drug developed by Novartis, may improve the effectiveness of cisplatin, one of the most common drugs used to treat mesothelioma....

2013-11-15 23:24:09

A combination of lung-sparing surgery and high-dose radiation may offer a "concrete therapeutic approach" to this hard-to-treat cancer. Raleigh, NC (PRWEB) November 15, 2013 Surviving Mesothelioma is reporting that medical researchers in Italy have achieved some of the best mesothelioma survival results seen in recent years using a combination approach that includes surgery, chemotherapy, and high-dose radiotherapy. Twenty patients with malignant pleural mesothelioma underwent...

2013-11-04 23:19:01

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022. London (PRWEB) November 04, 2013 PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch...

2013-11-04 23:04:31

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - UK Drug Forecast and Market Analysis to 2022. London (PRWEB) November 04, 2013 PharmaPoint: Non-Small Cell Lung Cancer - UK Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of...

2013-10-28 23:27:45

Australian scientists say altering the way cells express genes may give doctors a new way to combat malignant pleural mesothelioma. Raleigh, NC (PRWEB) October 28, 2013 In a study published in the Annals of Oncology and reported by Surviving Mesothelioma, researchers at the renowned Asbestos Diseases Research Institute in Sydney tested the role of microRNAs in mice with mesothelioma. MicroRNAs are tiny cell components responsible for the expression of a wide variety of genes, including...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related